SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

Clinical trial NCT07129187 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07129187
Sponsor: Chuan Wang
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early Breast Cancer HER2 + Breast Cancer Stage II Breast Cancer Stage III Breast Cancer

Start date: 2025-10-01
Primary completion: 2026-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.